Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FQPU2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,951
Award facts
- Contract value 100% obligated
- $18,950.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,950.64 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The contract carries no identified subcontractor relationships, with DMS Pharmaceutical Group serving as the sole prime contractor responsible for fulfillment.
This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support recurring pharmaceutical supply needs across Department of Defense military healthcare facilities worldwide. The underlying PPV-G GEN V IDC, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. The DLA's PPV-G GEN V program authorizes the issuance of firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables to support military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FQPU2?
SPE2DR26FQPU2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FQPU2 worth?
The government has obligated $18,951 on SPE2DR26FQPU2.
Is contract SPE2DR26FQPU2 an order under another contract?
Yes. SPE2DR26FQPU2 is a delivery order under SPE2DR25D9331, an indefinite delivery contract.
Was contract SPE2DR26FQPU2 competed?
The extent of competition for SPE2DR26FQPU2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award